Healthcare


 Genedrive (AIM: GDR) Receives FDA Breakthrough Device Designation for MT-RNR1 ID Kit

Genedrive (AIM: GDR) Receives FDA Breakthrough Device Designation fo...

July 15, 2024 08:04 AM BST | By Team Kalkine Media

Genedrive plc (,AIM: GDR,), a leader in point-of-care pharmacogenetic testing, has announced the receipt of Breakthrough Device Designation from the U...

 Scancell Holdings (AIM: SCLP) Strikes Exclusive Evaluation Deal with Major Biotech Firm

Scancell Holdings (AIM: SCLP) Strikes Exclusive Evaluation Deal with...

June 12, 2024 08:45 AM BST | By Team Kalkine Media

Scancell Holdings plc (,AIM: SCLP,), a pioneer in the realm of oncology immunotherapies, has made waves once again with a significant announcement. Th...

 ANGLE plc (AIM: AGL) Announces £8.5 Million Fundraising

ANGLE plc (AIM: AGL) Announces £8.5 Million Fundraising

June 05, 2024 09:23 AM BST | By Team Kalkine Media

ANGLE plc (,AIM: AGL,), a global leader in liquid biopsy technology, has announced plans for a significant fundraising effort aimed at raising approxi...

 Prescription for Profit: Investing in LON Healthcare Stocks for Healthy Returns and Market Dominance

Prescription for Profit: Investing in LON Healthcare Stocks for Heal...

June 22, 2023 11:26 AM BST | By Team Kalkine Media

The healthcare sector is a vital and ever-growing industry that offers significant investment opportunities. In this article, we will explore the worl...

 Healthcare stocks to explore amidst education and health sectors strikes

Healthcare stocks to explore amidst education and health sectors str...

May 15, 2023 08:56 AM BST | By Manu Shankar

Highlights The country was again in crisis as thousands of healthcare and education professionals went on strike, increasing the already prevalent...

 Stocks to watch as the UK invests in the fight against deadly diseases

Stocks to watch as the UK invests in the fight against deadly diseas...

November 14, 2022 02:10 PM GMT | By Rishika Raina

Over the course of 3 years, the UK is channelising funds worth £1 billion towards the Global Fund.

 Which FTSE health-related stocks to check out right now?

Which FTSE health-related stocks to check out right now?

November 14, 2022 11:10 AM GMT | By Abhishek Sharma

Highlights:,The Rishi Sunak government will face its first acid test as they gear up for the Autumn budget.,The fiscal statement is all set to be rele...

 AstraZeneca boosts earnings guidance while demand strengthens

AstraZeneca boosts earnings guidance while demand strengthens

November 10, 2022 01:44 PM GMT | By Rishika Raina

AstraZeneca declared its YTD and Q3 2022 results on Thursday.

 Key stocks to watch as new clinical trials in UK declines

Key stocks to watch as new clinical trials in UK declines

October 20, 2022 10:15 AM BST | By Rishika Raina

• The fall in clinical trials poses a severe threat to the country’s status as a clinical research hub.

 PM Truss urged to put billions into social care

PM Truss urged to put billions into social care

September 23, 2022 08:29 AM BST | By Rishika Raina

In her campaign, the PM had pledged to spend £13 billion on social care.

 Haleon IPO: GSK gets shareholders' nod; all you should know

Haleon IPO: GSK gets shareholders' nod; all you should know

July 07, 2022 08:45 AM BST | By Abhishek Sharma

Highlights:,GSK Plc on Wednesday received approval from the shareholders for the demerger of its consumer healthcare arm.,The new entity, called Haleo...

 AZN, GSK, HIK: Pharma stocks to consider amid fears of poliovirus spread

AZN, GSK, HIK: Pharma stocks to consider amid fears of poliovirus sp...

June 23, 2022 08:43 AM BST | By Abhishek Sharma

Highlights:,Several closely-related poliovirus samples were found in the North and East London sewage.,The detection indicates there's been some sprea...

 GSK's spin-off Haleon to be listed on LSE: Should you hold stock?

GSK's spin-off Haleon to be listed on LSE: Should you hold stock?

June 16, 2022 10:50 AM BST | By Abhishek Sharma

Pharma giant GSK plc (LON: GSK), which was previously known as GlaxoSmithKline plc, had in February announced that it would demerge its consumer healt...

 Should you go for GlaxoSmithKline (GSK) share after solid Q1 results?

Should you go for GlaxoSmithKline (GSK) share after solid Q1 results...

April 28, 2022 08:47 AM BST | By Team Kalkine Media

Highlights GlaxoSmithKline Plc announced its Q1 2022 results on Wednesday and surpassed expectations with a turnover of £9.8 billion. The...

 AstraZeneca vs GlaxoSmithKline: Pharma stocks to keep an eye on

AstraZeneca vs GlaxoSmithKline: Pharma stocks to keep an eye on

April 20, 2022 08:42 AM BST | By Rishika Raina

Leading British pharmaceutical company GlaxoSmithKline plc (LON: GSK) has been in the limelight lately after securing triumph for its drug with US reg...

 Is OKYO Pharma (LON: OKYO) going for a Nasdaq listing?

Is OKYO Pharma (LON: OKYO) going for a Nasdaq listing?

March 08, 2022 12:42 PM GMT | By Rishika Raina

Highlights OKYO Pharma is aiming to get its ADSs listed on Nasdaq and has submitted a registration statement with the US SEC for the same. The exc...

 GlaxoSmithKline (LON: GSK) to start a new business era with Haleon

GlaxoSmithKline (LON: GSK) to start a new business era with Haleon

February 23, 2022 09:28 AM GMT | By Sreenivas D Ajankar

Highlights GlaxoSmithKline Plc has come one step closer to the proposed demerger of its consumer healthcare business by announcing the name of the...

 AstraZeneca (AZN) predicts higher sales in 2022: Should you buy now?

AstraZeneca (AZN) predicts higher sales in 2022: Should you buy now?

February 11, 2022 06:43 AM GMT | By Rishika Raina

Highlights  London’s FTSE100 index was in a buoyant mood on 10 February after it saw third day of gains in a row. The total revenues of...

 GlaxoSmithKline (GSK) shares: Are they worth your attention?

GlaxoSmithKline (GSK) shares: Are they worth your attention?

February 10, 2022 10:21 AM GMT | By Priya Bhandari

British pharmaceutical giant GlaxoSmithKline Plc (LON: GSK) is back in the news after the company reported robust results for the year 2021 before the...

 GlaxoSmithKline (GSK) settles case with Gilead: Should you buy now?

GlaxoSmithKline (GSK) settles case with Gilead: Should you buy now?

February 02, 2022 01:52 PM GMT | By Sreenivas D Ajankar

The UK-based pharmaceutical company, GlaxoSmithKline Plc (LON: GSK), which is into research and development of medicine and consumer healthcare produc...

AI on the Rise: A Look at Top AI Companies and Their Stocks

Recent Articles

 Europe Needs Twisters Campaign
July 16, 2024 12:17 AM AEST | By Pressat

 European Broadcaster Arte Unveils Another App Optimised For Apple Vision Pro For European Launch
July 16, 2024 12:17 AM AEST | By Pressat

 Bwy And Yss® Team Up For ‘Game Changing’ Yoga In Sport Workshop
July 15, 2024 10:12 PM AEST | By Pressat

 Lucy Gilson And Johan Rockström Awarded The Virchow Prize 2024
July 15, 2024 08:45 PM AEST | By Pressat

 Voices Of Hope Launches The Pearl Project 2024: Celebrating The Resilience Of Survivors
July 15, 2024 08:17 PM AEST | By Pressat